180 related articles for article (PubMed ID: 35850677)
1. Assessing the accuracy of multiparametric MRI to predict clinically significant prostate cancer in biopsy naïve men across racial/ethnic groups.
Meza J; Babajide R; Saoud R; Sweis J; Abelleira J; Helenowski I; Jovanovic B; Eggener S; Miller FH; Horowitz JM; Casalino DD; Murphy AB
BMC Urol; 2022 Jul; 22(1):107. PubMed ID: 35850677
[TBL] [Abstract][Full Text] [Related]
2. Performance of prostate health index and PSA density in a diverse biopsy-naïve cohort with mpMRI for detecting significant prostate cancer.
Carbunaru S; Stinson J; Babajide R; Hollowell CMP; Yang X; Sekosan M; Ferrer K; Kajdacsy-Balla A; Abelleira J; Ruden M; King-Lee P; Dalton DP; Casalino DD; Kittles RA; Gann PH; Schaeffer EM; Murphy AB
BJUI Compass; 2021 Nov; 2(6):370-376. PubMed ID: 35474697
[TBL] [Abstract][Full Text] [Related]
3. Intermediate-term oncological outcomes after a negative endorectal coil multiparametric MRI of the prostate in patients without biopsy proven prostate cancer.
Kamal O; Comerford J; Foster BR; Young DJ; Amling C; Coakley FV
Clin Imaging; 2022 Dec; 92():112-116. PubMed ID: 36306588
[TBL] [Abstract][Full Text] [Related]
4. MRI-TRUS fusion biopsy of the prostate: Quality of image fusion in a clinical setting.
Schlenker B; Apfelbeck M; Buchner A; Stief C; Clevert DA
Clin Hemorheol Microcirc; 2018; 70(4):433-440. PubMed ID: 30347605
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic pathway of the biopsy-naïve patient suspected for prostate cancer: Real-life scenario when multiparametric Magnetic Resonance Imaging is not centralized.
Bertolo R; Vittori M; Cipriani C; Maiorino F; Forte V; Iacovelli V; Petta F; Sperandio M; Marani C; Panei M; Travaglia S; Bove P
Prog Urol; 2021 Oct; 31(12):739-746. PubMed ID: 33431200
[TBL] [Abstract][Full Text] [Related]
6. Optimizing detection of clinically significant prostate cancer through nomograms incorporating mri, clinical features, and advanced serum biomarkers in biopsy naïve men.
Siddiqui MR; Li EV; Kumar SKSR; Busza A; Lin JS; Mahenthiran AK; Aguiar JA; Shah PV; Ansbro B; Rich JM; Moataz SAS; Keeter MK; Mai Q; Mi X; Tosoian JJ; Schaeffer EM; Patel HD; Ross AE
Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):588-595. PubMed ID: 36973367
[TBL] [Abstract][Full Text] [Related]
7. Systematic versus Targeted Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy among Men with Visible Lesions.
Patel HD; Koehne EL; Shea SM; Fang AM; Gorbonos A; Quek ML; Flanigan RC; Goldberg A; Rais-Bahrami S; Gupta GN
J Urol; 2022 Jan; 207(1):108-117. PubMed ID: 34428091
[TBL] [Abstract][Full Text] [Related]
8. The predictive value of the prostate health index vs. multiparametric magnetic resonance imaging for prostate cancer diagnosis in prostate biopsy.
Stejskal J; Adamcová V; Záleský M; Novák V; Čapoun O; Fiala V; Dolejšová O; Sedláčková H; Veselý Š; Zachoval R
World J Urol; 2021 Jun; 39(6):1889-1895. PubMed ID: 32761380
[TBL] [Abstract][Full Text] [Related]
9. A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings.
Luzzago S; de Cobelli O; Cozzi G; Peveri G; Bagnardi V; Catellani M; Di Trapani E; Mistretta FA; Pricolo P; Conti A; Alessi S; Marvaso G; Ferro M; Matei DV; Renne G; Jereczek-Fossa BA; Petralia G; Musi G
BJU Int; 2020 Jul; 126(1):104-113. PubMed ID: 32150328
[TBL] [Abstract][Full Text] [Related]
10. Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
van der Leest M; Cornel E; Israël B; Hendriks R; Padhani AR; Hoogenboom M; Zamecnik P; Bakker D; Setiasti AY; Veltman J; van den Hout H; van der Lelij H; van Oort I; Klaver S; Debruyne F; Sedelaar M; Hannink G; Rovers M; Hulsbergen-van de Kaa C; Barentsz JO
Eur Urol; 2019 Apr; 75(4):570-578. PubMed ID: 30477981
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
12. Racial disparity in the utilization of multiparametric MRI-ultrasound fusion biopsy for the detection of prostate cancer.
Hoge C; Verma S; Lama DJ; Bergelson I; Haj-Hamed M; Maynor S; Gaitonde K; Sidana A
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):567-572. PubMed ID: 32152436
[TBL] [Abstract][Full Text] [Related]
13. Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial.
Tonttila PP; Lantto J; Pääkkö E; Piippo U; Kauppila S; Lammentausta E; Ohtonen P; Vaarala MH
Eur Urol; 2016 Mar; 69(3):419-25. PubMed ID: 26033153
[TBL] [Abstract][Full Text] [Related]
14. How to make clinical decisions to avoid unnecessary prostate screening in biopsy-naïve men with PI-RADs v2 score ≤ 3?
Zhang Y; Zeng N; Zhang F; Huang Y; Tian Y
Int J Clin Oncol; 2020 Jan; 25(1):175-186. PubMed ID: 31473884
[TBL] [Abstract][Full Text] [Related]
15. Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.
Alberts AR; Roobol MJ; Verbeek JFM; Schoots IG; Chiu PK; Osses DF; Tijsterman JD; Beerlage HP; Mannaerts CK; Schimmöller L; Albers P; Arsov C
Eur Urol; 2019 Feb; 75(2):310-318. PubMed ID: 30082150
[TBL] [Abstract][Full Text] [Related]
16. A Comparison of Image-Guided Targeted Prostate Biopsy Outcomes by PI-RADS® Score and Ethnicity in a Diverse, Multiethnic Population.
Hines L; Zhu D; DeMasi M; Babar M; Chernyak V; Kovac EZ; Aboumohamed A; Sankin A; Agalliu I; Watts KL
J Urol; 2021 Sep; 206(3):586-594. PubMed ID: 33881932
[TBL] [Abstract][Full Text] [Related]
17. Prospective nonrandomized study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy to magnetic resonance imaging with subsequent MRI-guided biopsy in biopsy-naïve patients.
Castellucci R; Linares Quevedo AI; Sánchez Gómez FJ; Díez Rodríguez J; Cogorno L; Cogollos Acuña I; Salmerón Béliz I; Muñoz Fernández de Legaría M; Martínez Piñeiro L
Minerva Urol Nefrol; 2017 Dec; 69(6):589-595. PubMed ID: 29094851
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the PI-RADSv2 classification in a cohort of patients who underwent a prostate fusion biopsy.].
Rodríguez Cabello MÁ; Sanz Migueláñez JL; Méndez Rubio S; Arias Fúnez F; Garrido Abad P; Carrillo Guivernau MJ; Velasco Ruíz M; González Gordaliza C; Platas Sancho A
Arch Esp Urol; 2020 Jan; 73(1):1-10. PubMed ID: 31950917
[TBL] [Abstract][Full Text] [Related]
19. High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility.
van der Leest M; Israël B; Cornel EB; Zámecnik P; Schoots IG; van der Lelij H; Padhani AR; Rovers M; van Oort I; Sedelaar M; Hulsbergen-van de Kaa C; Hannink G; Veltman J; Barentsz J
Eur Urol; 2019 Nov; 76(5):574-581. PubMed ID: 31167748
[TBL] [Abstract][Full Text] [Related]
20. Correlation of 3T multiparametric prostate MRI using prostate imaging reporting and data system (PIRADS) version 2 with biopsy as reference standard.
Mathur S; O'Malley ME; Ghai S; Jhaveri K; Sreeharsha B; Margolis M; Zhong L; Maan H; Toi A
Abdom Radiol (NY); 2019 Jan; 44(1):252-258. PubMed ID: 30032385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
